StonvexLoading…
StonvexStonvexStonvexCore line items from CYCN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2020 2020-12-31 | Q3 2020 2020-09-30 | Q2 2020 2020-06-30 | Q1 2020 2020-03-31 |
|---|---|---|---|---|
Revenue | $2.30M | $2.16M | $1.76M | $1.01M |
Operating Income | $-81.27M | $-62.04M | $-40.26M | $-20.59M |
Net Income | $-77.80M | $-58.57M | $-19.53M | $-20.23M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $115.38M | $131.40M | $128.04M | $140.03M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $54.40M | $66.84M | $56.46M | $67.10M |
Free Cash Flow OCF − CapEx | $-74.01M | $-59.94M | $-44.88M | $-30.59M |
Shares Outstanding | 34.05M | 33.96M | 27.86M | 27.75M |